Background and Objectives: Breast milk is a complex bioactive fluid that varies across numerous maternal and environmental conditions. Although breastfeeding is known to affect neonatal gut microbiome, the milk components responsible for this effect are not well-characterized. Given the wide range of immunological activity breast milk cytokines engage in, we investigated 3 essential breast milk cytokines and their association with early life gut microbiota. Methods: A total of 52 maternal-child pairs were drawn from a racially diverse birth cohort based in Detroit, Michigan. Breast milk and neonatal stool specimens were collected at 1-month postpartum. Breast milk transforming growth factor (TGF)b1, TGFb2, and IL-10 were assayed using enzyme-linked immunosorbent assays, whereas neonatal gut microbiome was profiled using 16S rRNA sequencing. Results: Individually, immunomodulators TGFb1 and TGFb2 were significantly associated with neonatal gut microbial composition (R 2 ¼ 0.024, P ¼ 0.041; R 2 ¼ 0.026, P ¼ 0.012, respectively) and increased richness, evenness, and diversity, but IL-10 was not. The effects of TGFb1 and TGFb2, however, were not independent of one another, and the effect of TGFb2 was stronger than that of TGFb1. Higher levels of TGFb2 were associated with the increased relative abundance of several bacteria, including members of Streptococcaceae and Ruminococcaceae, and lower relative abundance of distinct Staphylococcaceae taxa. Conclusions: Breast milk TGFb concentration explains a portion of variability in gut bacterial microbiota composition among breast-fed neonates. Whether TGFb acts in isolation or jointly with other bioactive components to alter bacterial composition requires further investigation. These findings contribute to an increased understanding of how breastfeeding affects the gut microbiome-and potentially immune development-in early life.
M
icrobes residing in the human gastrointestinal tract are being increasingly recognized for their essential role in defining human health. In addition to nutrient and energy extraction, gut microbes influence appropriate physiological and immune development and defend against pathogenic invasions (1) (2) (3) . After birth, a rapid expansion of intestinal bacterial diversity occurs in the first year of life before reaching a relatively stable state, which is typically maintained throughout healthy adulthood (4) . Microbiome development in early life occurs in parallel with immune maturation, and is thought to be foundational to health later in life. Indeed, dysbiotic patterns in early life are associated with the increased risk of several immunological diseases, including allergy and asthma (4) (5) (6) . Although colonization patterns occur in a greatly host-specific manner, early life exposures are key factors in the shaping of infant gut microbial communities, many of which involve maternal-offspring interactions and exchanges (7, 8) . Specifically, in addition to delivery mode, breast-feeding has been shown to be one of the strongest determinants of early life gut microbial composition (2, (8) (9) (10) . Breast milk, however, is a complex mixture that, in addition to nutritional factors, contains a variety of bioactive components, including immunoglobulins, fatty acids, hormones, cytokines, oligosaccharides, and bacteria. Furthermore, its constitution has been shown to vary depending on several maternal and environmental factors, including maternal age, diet, and country of origin (11, 12) . Therefore, although gut microbial composition of breast-fed children is compositionally distinct from that of formula-fed children (2, (8) (9) (10) , it is likely that the heterogeneity of breast milk components leads to differential gut microbiota development within breast-fed offspring; however, little is known of these relationships.
Cytokines are important constituents of breast milk with a wide range of immunological activity. They can cross the intestinal barrier and communicate with cells to influence immune development and maturation (13) . Although a number of different interleukins (ILs) have been detected in human breast milk, their levels are typically low (14) . Nonetheless, IL-10 has often been detected in substantial quantities, and is thought to inhibit TH1-type inflammation and facilitate immune tolerance (13, 14) . IL-10 has also been shown to play an important role in maintaining intestinal homeostasis in both murine models and humans (15, 16) . The transforming growth factor beta (TGFb) family is the most abundant family of cytokines in human breast milk and is expressed by many cell types, with TGFb2 being predominant (13) . Breast milk TGFb not only maintains immune homeostasis in the infant gut but also regulates inflammation, promotes IgA isotype switching to both IgA1 and IgA2 (17) , initiates IgA production in newborn infants (18) , and plays a major role in the induction of oral tolerance (14, 19) . Given the expansive immunological role these breast milk cytokines play in early life and their ability to alter the gastrointestinal environment, we hypothesized that they would be associated with gut bacterial composition among breast-fed neonates. We examined these associations among maternal-child pairs drawn from a metropolitan Detroit birth cohort, wherein participants were selected based on geographic area of residence and not on any parental disease history (20) .
METHODS

Study Population
The study population consisted of maternal-child pairs from the Wayne County Health Environment Allergy and Asthma Longitudinal Study (WHEALS), a general-risk, prospective birth cohort with racially and socioeconomically diverse participants. Briefly, pregnant women ages 21 to 49 years receiving care at Henry Ford Health System (HFHS) obstetrics clinics in urban and suburban Detroit were recruited from 2003 to 2007. All women were living in a predefined geographic area in Wayne and Oakland counties that included the western portion of the city of Detroit and the suburban areas immediately surrounding the city. All participants provided written, informed consent and the study was performed in accordance with protocol guidelines approved by the institutional review board at HFHS. Additional details about the cohort have been previously published (20) .
Inclusion/Exclusion Criteria
A subset of children was selected from the WHEALS cohort for inclusion in the Microbes, Allergy, Asthma, and Pets study if they completed a 24-month study-specific clinic visit and had early life dust samples collected from their homes at the same time as their stool collection (N ¼ 308). Early life stool samples were successfully sequenced from 298 infants (130 with 1-month stool samples and 168 with 6-month stool samples). Because breast milk samples were collected at the 1-month home visit (from mothers who were currently-but not necessarily exclusively-breastfeeding), only 1-month stool was analyzed for the current study so that breast milk and stool sample collection was concurrent. Among the 130 maternal-child pairs with 1-month stool samples, 52 also had a breast milk sample collected and analyzed for cytokine concentrations, which comprised our final analytic sample. Given the inclusion criteria and breast-feeding requirement, participants in the analytic sample (N ¼ 52) differed from WHEALS participants excluded (N ¼ 1206), as they were more likely to be married (P ¼ 0.019), white (P ¼ 0.004), have higher education (P < 0.001), and have higher incomes (P ¼ 0.017).
Breast Milk and Measurement of Cytokines
Two ounces of breast milk were collected from participants using a sterilized disposable breast pump kit (Medela Classic). Using a sterile pipette, 1-mL aliquots of whole breast milk were transferred into sterile cryovials. Breast milk samples were placed on ice until delivery to the Department of Public Health Sciences laboratory where the remaining breast milk was centrifuged at 48C to separate the lipid and aqueous fractions. After removal of the lipid layer, 1-mL aliquots of the aqueous fraction were transferred into cryovials and the whole milk, lipid layer, and aqueous fractions were stored at À808C. The aqueous fraction was used for assay of cytokines. TGFb1, TGFb2, and IL-10 were assayed using commercial enzyme-linked immunosorbent assays (R&D Systems, Minneapolis, MN) according to manufacturer instructions, with resulting concentrations expressed as picogram per milliliter. These specific cytokines were chosen because they were thought to be associated with risk of allergic disease, the focus of the WHEALS cohort. The minimum detectable concentrations were 4.6, 7.0, and 3.9 pg/mL for TGFb1, TGFb2, and IL-10, respectively. Samples below the minimum detectable concentration of IL-10 were reassayed with a high sensitivity IL-10 enzyme-linked immunosorbent assay (R&D Systems). Values below the minimum detectable concentration for the high sensitivity kit (0.09 pg/mL) were reported as half the minimum detectable concentration (0.045 pg/mL).
Stool Specimens and Gut Microbiota Sequencing
A detailed description of processing and sequencing protocols has been previously published (6) . Briefly, stool specimens were collected by field staff during the home visit, placed into cryovials, and stored at À808C until stool aliquots were shipped to University of California, San Francisco on dry ice, where they were again stored at À808C until processed. Stool samples were extracted using a modified cetyltrimethylammonium bromide buffer-based protocol, as previously described (6) . Bacterial communities were characterized by sequencing the V4 region of the 16S rRNA gene, using the Illumina MiSeq sequencing platform (21) . Sequence processing and quality assurance were conducted using the QIIME software version 1.8.0 (22) . The data were then rarefied to the minimum read depth of 202,367 sequences per sample, using a representative rarefying approach described previously (6) .
Statistical Analysis
For descriptive purposes, maternal and baseline covariates were examined for associations with raw breast milk cytokine concentrations using standard nonparametric statistical tests (Wilcoxon rank sum, Kruskal-Wallis, or Spearman correlation), which account for the skewed nature of raw cytokine distributions. Breast milk cytokine concentrations, however, were natural log-transformed before all microbiome-related analyses. Gut microbial alpha diversity metrics (richness, Pielou evenness, and Faith phylogenetic diversity) were calculated using QIIME (22) and the R vegan package (23) , and their associations with breast milk cytokines were assessed using Spearman correlations. Compositional differences (ie, beta diversity) in the gut microbiome were captured using an Unweighted UniFrac distance matrix (24) , a measure of between-sample phylogenetic similarity in terms of bacteria present in the gut. These distances were tested for compositional differences by breast milk cytokine levels using (unadjusted and adjusted) permutational multivariate analysis of variance (PERMANOVA) with 10,000 permutations, using the ''adonis'' function in the R vegan package (23) . Compositional differences were visualized using nonmetric multidimensional scaling (nMDS)-which attempts to group samples based on relative similarity-with the ''metaMDS'' function in the R vegan package. Contour lines were overlaid onto the nMDS plot using generalized additive models (GAMs) with the ''ordisurf'' function in the vegan package.
Tests of differential taxon relative abundance were performed on all taxa with at least 5 total sequences using zero-inflated negative binomial regression, or standard negative binomial regression in cases wherein the model failed to converge. Tests were then corrected for multiple comparisons using the Benjamini & Hochberg false discovery rate (FDR) adjustment (25) , with FDRadjusted P <0.05 considered significant. Phylogenetic trees of significant taxa were built using interactive tree of life (26) . As a means to determine the functional implications of significant taxa, their metagenomic function was predicted using the Phylogenetic Reconstruction of Unobserved States algorithm (27) . Predicted pathways were then tested for differences using the standard negative binomial model and FDR corrected, as described previously. All analyses were performed in R (Version 3.1.2) and SAS Software (Version 9.4; SAS Institute, Cary, NC).
RESULTS
Among the 52 maternal-child pairs included in the analysis, home visits wherein both milk and stool were collected successfully targeted 1 month of age (mean ¼ 36 days, interquartile range ¼ 17 days). All but 12 (23%) of the paired milk and stool samples were collected on the same day; otherwise, paired samples were collected within 7 days of each other. A total of 13 (25%) mothers reported exclusively breast-feeding at the study visit, whereas the remainder were partially breast-feeding. IL-10 concentrations were detectable in 30 (58%) breast milk samples, whereas TGFb1 and TGFb2 were detectable in all samples (median concentrations: 0.2, 1805.6, 2963.0 pg/mL, respectively).
Maternal marital status, urban residence, maternal race, maternal atopy, maternal age, and days postpartum at milk collection were associated with at least 1 of the 3 breast milk cytokines (all P < 0.05, Table 1 ). Specifically, maternal atopy was associated with significantly higher breast milk IL-10 concentrations (P ¼ 0.002), and concentrations of this cytokine were significantly lower in breast milk samples collected later in the postpartum period (P ¼ 0.005). African-American and urban-dwelling (which are greatly related in this cohort, x 2 , P ¼ 0.008) mothers had significantly higher concentrations of TGFb1, and unmarried mothers had significantly higher concentrations of both TGFb1 and TGFb2. Lastly, maternal age was significantly associated with TGFb2, with older mothers having lower concentrations.
Breast milk IL-10 was neither univariately (unweighted UniFrac: R 2 ¼ 0.017, P ¼ 0.84) nor multivariately associated with neonatal gut composition (Table 2) . Individually, however, concentrations in breast milk of both TGFb1 and TGFb2 were significantly associated with gut microbial composition in breast-fed neonates, with TGFb1 explaining 2.4% of the microbial variability (P ¼ 0.041) and TGFb2 explaining 2.6% (P ¼ 0.012). An nMDS ordination of unweighted UniFrac distances with fitted smooth curves for TGFb2 provided further support for this association (Fig. 1) , which was primarily explained by the first axis. Specifically, mothers of neonates positively loaded on the first axis tended to have lower levels of breast milk TGFb2 (Spearman r ¼ À0.38; P ¼ 0.005), as reflected by the vertical smooth curves in Figure 1 . When both TGFb1 and TGFb2 were included in a multivariate PERMANOVA model, each individual effect was no longer significant, demonstrating that their effects are not independent of one another. This result was somewhat expected, given that these 2 cytokines are greatly correlated with one another (Spearman r ¼ 0.80, P < 0.001). After adjusting for several potential confounders (Table 2) , the association between TGFb1 and neonatal gut composition was diminished, with the association being most influenced by maternal race (13% drop in R 2 ) and marital status (8% drop in R 2 ). The association with TGFb2, however, was not substantially affected by covariate adjustment.
Examining the association between breast milk cytokines and gut microbial alpha diversity metrics (Supplemental Digital Content 1, Table, http://links.lww.com/MPG/A956), higher concentrations of TGFb2 were consistently associated with higher gut richness (number of taxa detected; r ¼ 0.35, P ¼ 0.011), evenness (taxon distribution; r ¼ 0.36, P ¼ 0.008), and phylogenetic diversity (r ¼ 0.33, P ¼ 0.016). Similar associations were found for TGFb1, although effect sizes were smaller and often diminished after covariate adjustment. IL-10 was not associated with these metrics in either unadjusted or adjusted models.
Given the low rates of exclusive breast-feeding in this socioeconomically and racially diverse population (25% in the analytic sample), it was of interest to determine whether the association between breast milk cytokines and neonatal gut microbial composition was dependent upon frequency of breastfeeding. For each of the 3 breast milk cytokines, interactions were nonsignificant (all P > 0.44). Although these differences were not statistically significant, effect sizes were consistent with a doseresponse relationship, wherein IL-10, TGFb1, and TGFb2 explained a greater proportion of the variation among exclusively breast-fed neonates compared to partially breast-fed neonates (among exclusively breastfed neonates: R 2 ¼ 0.086, 0.067, 0.083; among partially breast-fed neonates: R 2 ¼ 0.024, 0.030, 0.030, respectively).
Given that breast milk TGFb2 appeared to be more strongly associated with neonatal gut microbial composition than TGFb1 (both in terms of effect size and persistence after covariate adjustment) and because the effects of TGFb1 and TGFb2 were not independent, taxaspecific tests were conducted to identify those associated with TGFb2. We identified a total of 700 taxa significantly associated with breast milk TGFb2, the majority of which were positively associated (428 [61%]). Neonates of mothers with higher concentrations of TGFb2 were enriched with members of Ruminococcaceae (22 positive of 24 significant ¼ 22/24), including Ruminococcus and Faecalibacterium, Streptococcaceae (20/25), including Streptococcus and Lactococcus, Moraxellaceae (8/8), including Acinetobacter, Erysipelotrichaceae (9/10), Xanthomonadaceae (6/6), and Prevotellaceae (7/8), and were depleted of multiple Staphylococcus taxa (5 negative of 5 significant ¼ 5/5; Fig. 2 
DISCUSSION
Although it is well-established that gut microbiota of breastfed neonates are distinct from gut microbiota of formula-fed neonates (2,9,10), it is less clear whether bioactive components of breast milk further differentiate neonatal gut microbial composition among breast-fed neonates. In the present study, we demonstrated that breast milk TGFb2 was significantly associated with neonatal gut bacterial composition among breast-fed neonates and explained 2.6% of its variation. This is a fairly large effect size considering that neonatal composition is greatly host-specific, and that current breast-feeding alone explains 2.1% of the variation among our larger cohort of 130 neonates (from which our analytic sample of 52 was drawn), using the same metric and statistical testing procedure (8) .Only 25% of mothers included, however, were exclusively breast-feeding, which is particularly relevant to understanding the true magnitude of the effect of TGFb2 on gut microbiota. There are several factors that complicate our ability to analyze the ''dose'' of TGFb among partially breast-fed neonates. We did not collect information on the total daily intake of formula per day and did not attempt to assess the quantity of breast milk consumed per day. The quantity of biologically active TGFb in formula consumed by each infant was also not measured. Studies, however, have suggested that bovine milk (which is most commonly used in infant formulas) is not identical to human milk in terms of TGFb composition. Although TGFb1 and 2 are present in fairly high levels in both humans and cows, the dominant isoform varies between the 2 species, and most TGFb in bovine colostrum is latent, whereas approximately half of TGFb in human colostrum is active (28) . Whether TGFb is latent or active is particularly important in the context of neonates, as newborn guts are generally not acidic enough to cause activation (28) . Additionally, manufacturing formula from bovine milk can affect the retention and stability of bioactive molecules (29) , including TGFb, which some studies have failed to detect in infant formula (30) . Furthermore, a study comparing bovine colostrum to bovine infant formula demonstrated that TGFb2 was abundant in colostrum but negligible in infant formula, and these differences were also reflected in the guts of preterm pigs fed these 2 diets (31). Owing to these dissimilarities, we performed an additional analysis stratified by exclusive versus partial breast-feeding, and found that TGFb2 explained more variation in gut microbiota composition among exclusively breast-fed neonates compared to partially breast-fed neonates, although these differences were not statistically significant. Future Association between each breast milk cytokine and gut microbiome composition, adjusted for specified covariate. studies seeking to disentangle these more detailed aspects of exclusive versus partial breast-feeding should ensure statistical power is adequate for subgroup analyses.
A major strength of our study is that conclusions are drawn from a population-based, racially diverse birth cohort representative of the general population living in and around Detroit (eg, not selected based on parental history of disease). Additionally, adjusted analyses were able to be performed with a wide range of sociocultural factors that may be associated with maternal breast milk constitution, which determined that the TGFb2/neonatal gut composition was independent of these factors. Notably, although previous studies have reported a decrease in TGFb levels over time (28) , we failed to detect an association between time of milk collection and TGFb levels, and adjusting for time did not meaningfully alter results. This may be, however, because of the relatively restricted age range we observed (mean ¼ 36 days, interquartile range ¼ 17 days). Nonetheless, additional information would be gained from studies examining longitudinal breast milk samples with respect to infant gut microbiota.
A natural next step in understanding the association between breast milk TGFb2 and neonatal gut microbial composition is the mechanism, or more specifically, whether TGFb2 acts independently to affect gut microbial composition, jointly with other bioactive components, or is a biomarker correlated with an underlying causal breast milk constituent, such as breast milk bacteria or specific oligosaccharides. For example, the fact that Streptococcus are some of the most abundant bacteria in colostrum and mature milk (32) makes it difficult to determine in an observational setting if breast milk TGFb2 is a marker for breast milk Streptococcus that are transferred to the neonatal gut, or if it alters neonatal gut Streptococcus abundance independently. To our knowledge, however, no studies have detected Ruminococcus in breast milk, making a simple bacterial transfer hypothesis unlikely in this particular case. A plausible alternative hypothesis, however, is that breast milk TGFb2 correlates with breast milk oligosaccharides, which have been shown to affect the presence of Ruminococcaceae in guts of breast-fed infants (33) . Given the limited number of breast milk components measured in the current analysis, further studies are needed to determine how other breast milk cytokines (eg, tumor necrosis factor a and interferong) (13) , and a broader array of milk components (oligosaccharides, lactoferrin, and microbes, among others), interact with one another and offspring gut microbiota.
TGFb2 may also play more of a causative role in the association with neonatal gut composition by facilitating the creation of a noninflammatory environment that favors particular microbes; TGFb2 can directly inhibit inflammation in immature intestinal epithelia (34) . TGFb has also been shown to decrease gut permeability by increasing the expression of tight junction proteins (35) , which may improve the epithelial colonization landscape in the developing gut for specific bacteria (36) . Furthermore, TGFb2 has been shown to act in synergy with lipopolysaccharide to stimulate epithelial repair mechanisms in pig intestines that are necessary to maintain homeostasis during gut colonization (31) . Additionally, intestinal homeostasis could be induced and maintained by TGFb2 induction of intestinal regulatory T cells (1) . So, through direct or indirect mechanisms of TGFb2, a noninflammatory environment could be established in the infant gut that creates and maintains a gut microbiome that is more balanced and diverse (37) . Further multidisciplinary investigations are required to explore these complex relationships to understand biological mechanisms.
Despite the observational nature of our study, we found that microbial composition in very early life varies by levels of TGFb1 and TGFb2, during the critical period when microbial succession occurs in parallel with immune system education and metabolic programming. Furthermore, TGFb2-associated bacteria were involved in a wide range of metabolic functions, including steroid and flavonoid biosynthesis, which may contribute to metabolic profile differentiation induced by breast-feeding compared to formula-feeding (38) . Additionally, given that several studies have found a protective effect of TGFb1 and TGFb2 against atopic disorders (19) -consistent with what we have previously found in this cohort (39)-it is conceivable that neonatal gut microbiota may partially mediate this association. Interestingly, a recent case-control study found that Streptococcus and Prevotella were increased in abundance in the guts of healthy controls compared to foodsensitized children (40) . Furthermore, a recent population-based birth cohort study found that Ruminococcaceae were protective against food sensitization at 1 year of age (41) . In this cohort, we observed that Faecalibacterium, Lactococcus, and Acinetobacter were enriched in healthy neonates at significantly reduced risk of developing childhood allergic sensitization and asthma (6) . Given our findings that breast milk TGFb2 is associated with the increased abundance of these specific taxa in the neonatal gut, this provides further support for a mediation hypothesis. Finally, because we observed that one aspect of breast milk constitution has a significant association with early life microbial colonization patterns, which have been shown to alter the risk of immunological diseases later in life, our findings suggest a possible explanation for the inconsistent epidemiological reports regarding the effect of breast-feeding on atopic disorders later in life (42) , and highlights the need to better subclassify breast-fed neonates based on maternal milk content.
In summary, breast milk TGFb2 is associated with bacterial composition within the breast-fed neonatal gastrointestinal tract, indicating that further gut microbiome variability can be explained beyond breast-feeding status through the examination of maternal breast milk constitution. Although there is a conceivable direct link between breast milk TGFb and intestinal microbes, additional studies are needed to understand the underlying mechanisms. These findings may contribute to an improved comprehension of how breast-feeding affects immune development in early life, and adds valuable information in terms of characterizing the composition of neonatal gut microbial communities.
